The study concluded that tirzepatide was indeed associated with worsening of existing DR: 1.1% (n=33) of patients treated with tirzepatide developed PDR vs
Well Help You Center for Discovery provides measurement-based care for eating disorders with comprehensive teams who collaborate on complex cases, including those involving GLP-1 and eating disorders
Interpretation depends on formulation, exposure, route, population, and the exact endpoint studied
However, clinical trials have specific inclusion and exclusion criteria and may not capture all real-world experiences, particularly rare or subtle effects that might emerge with broader population exposure
The safest approach is to take your injection on the same day each week and treat early dosing as an occasional accommodation rather than a routine habit
Most of what is known comes from the individual mechanisms of these substances and anecdotal reports from patients and healthcare providers